In 11 studies of CD45RA/RO expression by Treg in blood of MS patients11,14,22,24,27,29,31,33–35,37, two studies used CD45RA for longitudinal monitoring of Treg in MS but did not compare to HD33,35. Here, CALR is linked to myeloid sarcoma.